Haemonetics Corp (HAE)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$82.07

Buy

$84.50

arrow-down$-0.96 (-1.14%)

Prices updated at 12 Dec 2025, 21:18 EST
| Prices minimum 15 mins delay
|
Prices in USD

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

Income statement

20242025
1,309m1,361m
692m749m
173m201m
13.2414.78
118m168m
262m337m
Sales, General and administrative432m437m
Interest expenses13m10m
Provision for income taxes34m44m
Operating expenses518m548m
Income before taxes152m212m
Net income available to common shareholders118m168m
2.563.43
Net interest income-13m-10m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)2.543.42
Free cash flow per share0.39583.7888
Book value/share17.494818.8487
Debt equity ratio0.8308311.122307

Balance sheet

20242025
Current assets769m935m
Current liabilities300m578m
Total capital1,758m1,742m
Total debt808m1,225m
Total equity960m821m
Total non current liabilities--
Loans798m921m
Total assets2,196m2,451m
Total liabilities--
Cash and cash equivalents179m307m
Common stock51m48m

Cash flow

20242025
Cash at beginning of period284m179m
Cash dividends paid--
115m142m
Investments (gains) losses-322m-162m
179m307m
Net income--
182m182m
-66m-39m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.